A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

Clinical trial NCT06215950 · RECRUITING

Trial details

NCT number: NCT06215950
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Cervix Cancer Metastatic Cancer Advanced Cancer Gynecologic Cancer

Start date: 2024-01-10
Primary completion: 2026-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.